In conclusion this study highlights the pertinence of highly significant risk alleles identified in 437 CML patients out of 16 561 SNPs, and also provides a rationale for evaluating implicated genes for their potential role in CML development.
← all excerpts
Genetic polymorphisms associated with increased risk of developing chronic myelogenous leukemia.
1
—
—